Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-31 Purchase |
2025-02-04 4:45 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
60,000 | $1.7241 | $103,446 | 149,551 (Direct) |
View |
| 2023-09-11 Sale |
2023-09-13 4:11 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
5,000 | $25.05 | $125,238 | 47,970 (Direct) |
View |
| 2021-05-11 Sale |
2021-05-13 4:12 pm |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
130,500 | $9.2083 | $1,201,683 | 1,580,302 (Direct) |
View |
| 2021-01-13 Sale |
2021-01-15 4:19 pm |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
25,000 | $15.03 | $375,787 | 2,519,581 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-21 Option Award |
2024-06-21 5:11 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
41,581 | $0 | 89,551 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-13 4:30 pm |
N/A 2034-06-12 |
Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director |
22,100 | $0 | 22,100 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-16 5:01 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
16,364 | $0 | 52,970 (Direct) |
View |
| 2023-06-14 Option Award |
2023-06-15 4:29 pm |
N/A 2033-06-13 |
Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director |
20,500 | $0 | 20,500 (Direct) |
View |
| 2023-03-30 Option Award |
2023-03-31 4:15 pm |
N/A 2033-03-29 |
Monte Rosa Therapeutics Inc. | GLUE | Skvarka Jan Director |
41,000 | $0 | 41,000 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-12 07:07 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Skvarka Jan Director |
36,606 | $0 | 36,606 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
43,000 | $0.314 | 1,580,302 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A 2029-09-25 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
130,500 | $0 | 1,580,302 (Direct) |
View |
| 2021-05-11 Exercise |
2021-05-13 4:12 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
87,500 | $0.4462 | 1,580,302 (Direct) |
View |
| 2021-01-14 Exercise |
2021-01-15 4:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
19,581 | $0.4275 | 2,519,581 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:19 pm |
N/A N/A |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
5,419 | $0.4248 | 2,519,581 (Direct) |
View |
| 2021-01-13 Exercise |
2021-01-15 4:19 pm |
N/A 2029-09-25 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
25,000 | $0 | 2,519,581 (Direct) |
View |
Ownership |
2021-01-04 8:11 pm |
N/A 2030-12-23 |
Trillium Therapeutics Inc. | TRIL | Skvarka Jan President and CEO |
0 | $0 | 2,115,000 (Direct) |
View |